Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 152 | 1 | 165 | +14 |
| Shares | 106.5M | 113 | 119.7M | +13.2M (+12.4%) |
| Value | $1.28B | $1.36K | $979.6M | −$298.3M (−23.3%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (35)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (21)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Nicholas Investment Partners, LP | 220,735 | $2.65M |
| Resolute Capital Asset Partners LLC | 167,515 | $2.01M |
| StemPoint Capital LP | 166,461 | $2.00M |
| Driehaus Capital Management LLC | 148,778 | $1.79M |
| Exome Asset Management LLC | 120,644 | $1.45M |
| Caption Management, LLC | 49,389 | $592.7K |
| Prelude Capital Management, LLC | 33,037 | $396.4K |
| Dark Forest Capital Management LP | 29,851 | $358.2K |
| Susquehanna Portfolio Strategies, LLC | 27,524 | $330.3K |
| Legato Capital Management LLC | 23,396 | $280.8K |
| Fox Run Management, L.L.C. | 16,887 | $202.6K |
| Susquehanna International Group, LLP | 16,348 | $196.2K |
| Jain Global LLC | 15,154 | $181.8K |
| Clear Harbor Asset Management, LLC | 15,119 | $181.4K |
| Skopos Labs, Inc. | 17,082 | $176.1K |
| Campbell & CO Investment Adviser LLC | 13,970 | $167.6K |
| Wealth Enhancement Advisory Services, LLC | 10,002 | $141.2K |
| JPL Wealth Management, LLC | 95 | $1.14K |
| US Bancorp | 34 | $408 |
| Larson Financial Group LLC | 3 | $36 |
| Allworth Financial LP | 2 | $24 |
Not filed for Q4 2025 yet (1)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 Europe (London) LLP | 113 | $1.36K |